LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,093
تعداد مقالات10,030
تعداد مشاهده مقاله27,416,460
تعداد دریافت فایل اصل مقاله7,569,485
Sharaf Eldeen, Doaa Ali, Elkareem Toson, Eman Abd, Elraheem Alshahat, Maiy Abd, Taha, Ahmed. (1391). Concurrent Hypofractionated Three-dimensional Re-irradiation and Temozolomide in Recurrent Malignant Glioma. سامانه مدیریت نشریات علمی, 3(Issue 2-3), 65-73.
Doaa Ali Sharaf Eldeen; Eman Abd Elkareem Toson; Maiy Abd Elraheem Alshahat; Ahmed Nageeb Taha. "Concurrent Hypofractionated Three-dimensional Re-irradiation and Temozolomide in Recurrent Malignant Glioma". سامانه مدیریت نشریات علمی, 3, Issue 2-3, 1391, 65-73.
Sharaf Eldeen, Doaa Ali, Elkareem Toson, Eman Abd, Elraheem Alshahat, Maiy Abd, Taha, Ahmed. (1391). 'Concurrent Hypofractionated Three-dimensional Re-irradiation and Temozolomide in Recurrent Malignant Glioma', سامانه مدیریت نشریات علمی, 3(Issue 2-3), pp. 65-73.
Sharaf Eldeen, Doaa Ali, Elkareem Toson, Eman Abd, Elraheem Alshahat, Maiy Abd, Taha, Ahmed. Concurrent Hypofractionated Three-dimensional Re-irradiation and Temozolomide in Recurrent Malignant Glioma. سامانه مدیریت نشریات علمی, 1391; 3(Issue 2-3): 65-73.

Concurrent Hypofractionated Three-dimensional Re-irradiation and Temozolomide in Recurrent Malignant Glioma

Middle East Journal of Cancer
مقاله 5، دوره 3، Issue 2-3، مهر 2012، صفحه 65-73    اصل مقاله (348.22 K)
نوع مقاله: Original Article(s)
نویسندگان
Doaa Ali Sharaf Eldeen1؛ Eman Abd Elkareem Toson* 1؛ Maiy Abd Elraheem Alshahat1؛ Ahmed Nageeb Taha2
1Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2Neurosurgery Department, Faculty of Medicine, Mansoura University. Mansoura, Egypt
چکیده
Background: This study determines the efficacy and tolerability of hypofraction- ated three-dimensional conformal radiotherapy in conjunction with daily temozolomide in treatment of previously irradiated recurrent malignant glioma.Methods:We enrolled 21 patients diagnosed with recurrent or progressive malignant glioma who previously underwent external beam irradiation. All patients had hypofrac- tionated three-dimensional conformal radiotherapy to a total dose of 30 Gy in six fractions, over a two-week period, concurrent with daily temozolomide (75 mg/m2).Results: At the median follow up of 9.5 months (range: 2.5-42), there were 18 (86%) patients who had died. Median overall survival from the onset of hypofractionated three- dimensional conformal radiotherapy was nine months and median time to progression was five months. There was no detectable severe toxicity. Salvage surgery prior to hypofractionated three-dimensional conformal radiotherapy and planning target volume significantly influenced patient outcome according to multivariate analysis.Conclusion: Hypofractionated conformal re-irradiation concurrent with daily temozolomide is a feasible, well-tolerated treatment for recurrent malignant glioma. Patients with surgical re-resection and smaller planning target volumes have the most favorable outcomes.
آمار
تعداد مشاهده مقاله: 3,130
تعداد دریافت فایل اصل مقاله: 505


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب